BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Colorectal cancer

1. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. COL2A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. PMS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. BMPR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. TOP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. SEPT9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. ALDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. LEF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. RNF43
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. PTPN13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. ACVR2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. PPARG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. SPECC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. BCL9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. SFPQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. WRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. HNF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. FLCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. PIK3R1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. EML4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. EZR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. SFRP4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. SUZ12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. DDX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. PER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. AMER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. MAP2K2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. RAD21
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. BCL9L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. BTK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. CIITA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. KMT2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. PTK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. SETBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. MYCL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. POT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. DDX6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. PALB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. RBM15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. SF3B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301.